Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002684.SZ
Valuation Bad
0%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Bad
0%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q1 Δ in %
Current Ratio 7.20 0.40 0.37
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 12.78 -29.56 -33.89
Naive Interpretation member
2 Per Share
Metric Q3 Q1 Δ in %
Book Value 99.51 -0.02 -4.66
Cash 113.39 0.18 0.09
Capex 62.70 < 0.005 -0.02
Free Cash Flow 23.03 0.12 0.10
Revenue 26.44 0.45 0.36
Naive Interpretation member
3 Profitability
Metric Q3 Q1 Δ in %
Gross Margin -6.02 0.12 0.13
Operating Margin -15.77 -0.32 -0.28
ROA 27.91 -0.03 -0.04
ROE 12893.50 9.22 0.07
ROIC -58.43 -0.02 -0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002684.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002684.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002684.SZ is permitted for members.